{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:01:32Z","timestamp":1783144892453,"version":"3.54.6"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82270684"],"award-info":[{"award-number":["No. 82270684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82203075"],"award-info":[{"award-number":["No.82203075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Local invasion is considered a premonitor of tumor metastasis which cause curative difficulties and undesired prognosis in patients with Pancreatic ductal adenocarcinoma (PDAC). The importance of mRNA N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) modification during tumor invasion is controversial as it plays distinct roles which mainly attributed to different m\n                    <jats:sup>6<\/jats:sup>\n                    A reader proteins exert function. In current study, the level of m\n                    <jats:sup>6<\/jats:sup>\n                    A expression in PDAC was analyzed by IHC and ELISA, all m\n                    <jats:sup>6<\/jats:sup>\n                    A-regulated genes in PDAC detected by qPCR. The downstream gene\n                    <jats:italic>EMP1<\/jats:italic>\n                    was screened by analyzing\n                    <jats:italic>IGF2BP3<\/jats:italic>\n                    knockdown RNA-seq,\n                    <jats:italic>IGF2BP3<\/jats:italic>\n                    -RIP, MeRIP-seq, and PDAC-survival related genes. And m\n                    <jats:sup>6<\/jats:sup>\n                    A modification sites of\n                    <jats:italic>EMP1<\/jats:italic>\n                    RNA was verified by MeRIP-qPCR, RIP-qPCR, and dual luciferase assays.\n                    <jats:italic>EMP1<\/jats:italic>\n                    -binding protein\n                    <jats:italic>VASP<\/jats:italic>\n                    was identified by mass spectrometry. Cell migration and invasive activity were detected using cytoskeletal staining, scratch assay, transwell assay, subcutaneous tumor and lung metastasis models. Finally, prognosis and immune microenvironment was analyzed in PDAC by IHC and multiple immunofluorescence staining. This work shows that m\n                    <jats:sup>6<\/jats:sup>\n                    A reader\n                    <jats:italic>IGF2BP3<\/jats:italic>\n                    is remarkably upregulated in local invasion PDAC and indicates worse prognosis of patients. Mechanistically,\n                    <jats:italic>IGF2BP3<\/jats:italic>\n                    recognized m\n                    <jats:sup>6<\/jats:sup>\n                    A-modified\n                    <jats:italic>EMP1<\/jats:italic>\n                    mRNAs to prolong stability of them, which inhibits the hindrance of\n                    <jats:italic>SMAD7<\/jats:italic>\n                    to\n                    <jats:italic>SMAD3\/4<\/jats:italic>\n                    phosphorylation by promoting the binding of\n                    <jats:italic>VASP<\/jats:italic>\n                    and\n                    <jats:italic>SMAD7<\/jats:italic>\n                    . Finally, a tight correlation of the local invasion\/\n                    <jats:italic>IGF2BP3\/EMP1<\/jats:italic>\n                    and infiltration of immune cells in the tumor microenvironment is evidenced in clinical PDAC. In conclusions,\n                    <jats:italic>IGF2BP3<\/jats:italic>\n                    functions as an invasion driver that induces PDAC development via the\n                    <jats:italic>EMP1\/TGF-\u03b2<\/jats:italic>\n                    axis. And\n                    <jats:italic>IGF2BP3\/EMP1<\/jats:italic>\n                    axis may be involved in regulating microenvironmental remodeling in pancreatic cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08155-1","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:28:18Z","timestamp":1764005298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-\u03b2 pathway to promote pancreatic cancer invasion"],"prefix":"10.1038","volume":"16","author":[{"given":"Long","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-8102","authenticated-orcid":false,"given":"Zheping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-0568","authenticated-orcid":false,"given":"Zhenzhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-3546","authenticated-orcid":false,"given":"Sheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"8155_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"8155_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. O\u2019Reilly, pancreatic cancer: a review. JAMA. 2021;326:851\u201362.","journal-title":"JAMA"},{"key":"8155_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0858-1","volume":"17","author":"B Ren","year":"2018","unstructured":"Ren B, Cui M, Yang G, Wang H, Feng M, You L, et al. Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018;17:108.","journal-title":"Mol Cancer"},{"key":"8155_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, Yang G, Zhou W, Qiu J, Chen G, Luo W, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14:14.","journal-title":"J Hematol Oncol"},{"key":"8155_CR5","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379.","journal-title":"Cell"},{"key":"8155_CR6","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1126\/science.abc1944","volume":"371","author":"JJ Quinn","year":"2021","unstructured":"Quinn JJ, Jones MG, Okimoto RA, Nanjo S, Chan MM, Yosef N, et al. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science. 2021;371:6532.","journal-title":"Science"},{"key":"8155_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"8155_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04950-2","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, He H, Zhang F, Hu X, Bi F, Li K, et al. m6A methylated EphA2 and VEGFA through IGF2BP2\/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K\/AKT and ERK1\/2 signaling. Cell Death Dis. 2022;13:483.","journal-title":"Cell Death Dis"},{"key":"8155_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.","journal-title":"Nat Commun"},{"key":"8155_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"8155_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41556-025-01667-0","volume":"27","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhou Y, Xue C, Zeng L, Deng S, Xu Z. Psychological stress-induced ALKBH5 deficiency promotes tumour innervation and pancreatic cancer via extracellular vesicle transfer of RNA. Nat Cell Biol. 2025;27:1035\u201347.","journal-title":"Nat Cell Biol"},{"key":"8155_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01158-w","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, Li K, Jiang W, Hu Y, Xiao W, Huang Y, et al. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Mol Cancer. 2020;19:91.","journal-title":"Mol Cancer"},{"key":"8155_CR13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Cancer Res. 2023;83:2187\u2013207.","journal-title":"Cancer Res"},{"key":"8155_CR14","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-23-0557","volume":"83","author":"J Tang","year":"2023","unstructured":"Tang J, Wang S, Weng M, Guo Q, Ren L, He Y, et al. The IGF2BP3-COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression. Cancer Res. 2023;83:3593\u2013610.","journal-title":"Cancer Res"},{"key":"8155_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21:60.","journal-title":"Mol Cancer"},{"key":"8155_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbcan.2017.04.004","volume":"1868","author":"YW Wang","year":"2017","unstructured":"Wang YW, Cheng HL, Ding YR, Chou LH, Chow NH. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer. Biochim Biophys Acta Rev Cancer. 2017;1868:199\u2013211.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8155_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40164-022-00321-x","volume":"11","author":"N Zhang","year":"2022","unstructured":"Zhang N, Zhu HP, Huang W, Wen X, Xie X, Jiang X, et al. Unraveling the structures, functions and mechanisms of epithelial membrane protein family in human cancers. Exp Hematol Oncol. 2022;11:69.","journal-title":"Exp Hematol Oncol"},{"key":"8155_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","volume":"611","author":"A Ca\u00f1ellas-Socias","year":"2022","unstructured":"Ca\u00f1ellas-Socias A, Cortina C, Hernando-Momblona X, Palomo-Ponce S, Mulholland EJ, Turon G, et al. Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells. Nature. 2022;611:603\u201313.","journal-title":"Nature"},{"key":"8155_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41556-022-00962-4","volume":"24","author":"G Guo","year":"2022","unstructured":"Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, et al. EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation. Nat Cell Biol. 2022;24:1291\u2013305.","journal-title":"Nat Cell Biol"},{"key":"8155_CR20","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41587-019-0246-4","volume":"37","author":"L Ye","year":"2019","unstructured":"Ye L, Park JJ, Dong MB, Yang Q, Chow RD, Peng L, et al. In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nat Biotechnol. 2019;37:1302\u201313.","journal-title":"Nat Biotechnol"},{"key":"8155_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50:1\u201314.","journal-title":"Exp Mol Med"},{"key":"8155_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2018","unstructured":"Becht E, McInnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2018;37:38\u201344.","journal-title":"Nat Biotechnol"},{"key":"8155_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109442","volume":"36","author":"Y Yang","year":"2021","unstructured":"Yang Y, Sun H, Zhang Y, Zhang T, Gong J, Wei Y, et al. Dimensionality reduction by UMAP reinforces sample heterogeneity analysis in bulk transcriptomic data. Cell Rep. 2021;36:109442.","journal-title":"Cell Rep"},{"key":"8155_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41418-021-00888-8","volume":"30","author":"H Yin","year":"2023","unstructured":"Yin H, Chen L, Piao S, Wang Y, Li Z, Lin Y, et al. M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1\/SMAD2\/SMAD3 pathway. Cell Death Differ. 2023;30:605\u201317.","journal-title":"Cell Death Differ"},{"key":"8155_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Mousa M, Nadukkandy AS, Franssens L, Alnaqbi H, Alshamsi FY, et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat Rev Cancer. 2023;23:544\u201364.","journal-title":"Nat Rev Cancer"},{"key":"8155_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:91.","journal-title":"Nucleic Acids Res"},{"key":"8155_CR27","doi-asserted-by":"publisher","first-page":"28824","DOI":"10.1074\/jbc.270.48.28824","volume":"270","author":"V Taylor","year":"1995","unstructured":"Taylor V, Welcher AA, Program AE, Suter U. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem. 1995;270:28824\u201333.","journal-title":"J Biol Chem"},{"key":"8155_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1359","volume":"13","author":"WJ Ni","year":"2023","unstructured":"Ni WJ, Zhou H, Lu H, Ma NN, Hou BB, Li W, et al. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Clin Transl Med. 2023;13:1359.","journal-title":"Clin Transl Med"},{"key":"8155_CR29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","volume":"72","author":"Y Bao","year":"2023","unstructured":"Bao Y, Zhai J, Chen H, Wong CC, Liang C, Ding Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72:1497\u2013509.","journal-title":"Gut"},{"key":"8155_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s11658-024-00545-1","volume":"29","author":"L Lv","year":"2024","unstructured":"Lv L, Wei Q, Zhang J, Dong Y, Shan Z, Chang N, et al. IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. Cell Mol Biol Lett. 2024;29:39.","journal-title":"Cell Mol Biol Lett"},{"key":"8155_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25345-5","volume":"12","author":"KP Hoefig","year":"2021","unstructured":"Hoefig KP, Reim A, Gallus C, Wong EH, Behrens G, Conrad C, et al. Defining the RBPome of primary T helper cells to elucidate higher-order Roquin-mediated mRNA regulation. Nat Commun. 2021;12:5208.","journal-title":"Nat Commun"},{"key":"8155_CR32","doi-asserted-by":"publisher","first-page":"1009882","DOI":"10.1371\/journal.ppat.1009882","volume":"18","author":"OMS Carmo","year":"2022","unstructured":"Carmo OMS, Shami GJ, Cox D, Liu B, Blanch AJ, Tiash S, et al. Deletion of the Plasmodium falciparum exported protein PTP7 leads to Maurer\u2019s clefts vesiculation, host cell remodeling defects, and loss of surface presentation of EMP1. PLoS Pathog. 2022;18:1009882.","journal-title":"PLoS Pathog"},{"key":"8155_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun BF, Chen CY, Zhou JY, Chen YS, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725\u201338.","journal-title":"Cell Res"},{"key":"8155_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat Commun. 2023;14:797.","journal-title":"Nat Commun"},{"key":"8155_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2023.05.036","volume":"165","author":"S Yousuf","year":"2023","unstructured":"Yousuf S, Qiu M, Voith von Voithenberg L, Hulkkonen J, Macinkovic I, Schulz AR, et al. Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer. Gastroenterology. 2023;165:891\u2013908.e14.","journal-title":"Gastroenterology"},{"key":"8155_CR36","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1158\/2159-8290.CD-21-1248","volume":"12","author":"A Schalck","year":"2022","unstructured":"Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes TG, Reuben A, et al. Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer. Cancer Discov. 2022;12:2330\u201349.","journal-title":"Cancer Discov"},{"key":"8155_CR37","first-page":"3","volume":"9","author":"JS Shankara Narayanan","year":"2023","unstructured":"Shankara Narayanan JS, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. J Immunother Cancer. 2023;9:3","journal-title":"J Immunother Cancer"},{"key":"8155_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","volume":"161","author":"NR Gough","year":"2021","unstructured":"Gough NR, Xiang X, Mishra L. TGF-\u03b2 Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer. Gastroenterology. 2021;161:434\u2013452.e15.","journal-title":"Gastroenterology"},{"key":"8155_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495\u2013501.","journal-title":"Nature"},{"key":"8155_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-022-02516-w","volume":"41","author":"DD Cave","year":"2022","unstructured":"Cave DD, Buonaiuto S, Sainz B Jr, Fantuz M, Mangini M, Carrer A, et al. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. J Exp Clin Cancer Res. 2022;41:315.","journal-title":"J Exp Clin Cancer Res"},{"key":"8155_CR41","doi-asserted-by":"publisher","first-page":"3.","DOI":"10.1136\/jitc-2020-002068","volume":"9","author":"D Melisi","year":"2021","unstructured":"Melisi D, Oh DY, Hollebecque A, Calvo E, Varghese A, Borazanci E. Safety and activity of the TGF\u00e1 receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. J Immunother Cancer. 2021;9:3.","journal-title":"J Immunother Cancer"},{"key":"8155_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"8155_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","volume":"10","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. 2017;10:36.","journal-title":"J Hematol Oncol"},{"key":"8155_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery FJ, Krishna S, Yossef R, Parikh NB, Chatani PD, Zacharakis N, et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science. 2022;375:877\u201384.","journal-title":"Science"},{"key":"8155_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14:173.","journal-title":"J Hematol Oncol"},{"key":"8155_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","volume":"32","author":"A L\u00f3pez-Soto","year":"2017","unstructured":"L\u00f3pez-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of Metastasis by NK Cells. Cancer Cell. 2017;32:135\u201354.","journal-title":"Cancer Cell"},{"key":"8155_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394.","journal-title":"Nat Commun"},{"key":"8155_CR48","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82:1660\u201377.","journal-title":"Mol Cell"},{"key":"8155_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295.","journal-title":"Nat Commun"},{"key":"8155_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41576-023-00685-8","volume":"25","author":"E Armingol","year":"2024","unstructured":"Armingol E, Baghdassarian HM, Lewis NE. The diversification of methods for studying cell-cell interactions and communication. Nat Rev Genet. 2024;25:381\u2013400.","journal-title":"Nat Rev Genet"},{"key":"8155_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121121","volume":"311","author":"P Godara","year":"2022","unstructured":"Godara P, Naik B, Meghwal R, Ojha R, Srivastava V, Prajapati VK, et al. Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria. Life Sci. 2022;311:121121.","journal-title":"Life Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08155-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08155-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08155-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:13:55Z","timestamp":1764180835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08155-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8155"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08155-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Medical Ethics Committee of The Second Affiliated Hospital of Zhejiang University School of Medicine. For in vivo tumor experiments, all procedures were approved by the Institutional Animal Care and Use Committees of The Second Affiliated Hospital of Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read and approved the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"858"}}